Design and synthesis of bile acid derivatives and their activity against colon cancer

RSC Medicinal Chemistry
2022.0

Abstract

Bile acids (BAs) containing both hydrophilic hydroxyl and carboxyl groups and hydrophobic methyl and steroid nuclei can promote the absorption of fat and other substances in the intestine, and they are synthesized by cholesterol in the liver and then returned to the liver through enteric liver circulation. Because there are many BA receptors on the cell membrane of colon tissues, BAs can improve the specific delivery and transport of medicines to colon tissues. Moreover, BAs have a certain anticancer and inflammation activity by themselves. Based on this theory, a series of BA derivatives against colon cancer including cholic acid (CA), chenodeoxycholic acid (CDCA), ursodeoxycholic acid (UDCA) and lithocholic acid (LCA) were designed and synthesized, and their antitumor activity was evaluated. For <i>in vitro</i> anti-tumor tests, all the compounds displayed cell proliferative inhibition to nine human malignant tumor cell lines to some degree, and in particular they showed stronger inhibition to the colon cancer cells than the other cell lines. Among them, four compounds (4, 5, 6, and 7) showed stronger activity than the other compounds as well as the positive control 5-FU against HCT116 cells, and their IC<sub>50</sub> was between 21.32 μmol L<sup>-1</sup> and 28.90 μmol L<sup>-1</sup>; cell clone formation and migration tests showed that they not only effectively inhibited the formation of HCT116 cell colonies, but also inhibited the HCT116 cell migration and invasion; moreover, they induced apoptosis, arrested the mitotic process at the G2/M phase of the cell cycle, reduced the mitochondrial membrane potential, increased the intracellular ROS levels, and reduced the expression of Bcl-2 and p-STAT3 in HCT 116 cells. In addition, they also displayed intermediate anti-inflammatory activity by inhibiting inflammatory mediators NO and downregulating TNF-α expression, which also is one of the causes of colon cancer. This suggests that they deserve to be further investigated as candidates for colon cancer treatment drugs.

Knowledge Graph

Similar Paper

Design and synthesis of bile acid derivatives and their activity against colon cancer
RSC Medicinal Chemistry 2022.0
Synthesis and biological evaluation of novel aniline-derived asiatic acid derivatives as potential anticancer agents
European Journal of Medicinal Chemistry 2014.0
Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety
European Journal of Medicinal Chemistry 2012.0
Synthesis and antitumor activity of novel 3-oxo-23-hydroxybetulinic acid derivatives
European Journal of Medicinal Chemistry 2014.0
Synthesis of heterocycle-modified betulinic acid derivatives as antitumor agents
European Journal of Medicinal Chemistry 2015.0
Synthesis and screening of ursolic acid-benzylidine derivatives as potential anti-cancer agents
European Journal of Medicinal Chemistry 2016.0
Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives
European Journal of Medicinal Chemistry 2011.0
Bile acid toxicity structure–activity relationships: Correlations between cell viability and lipophilicity in a panel of new and known bile acids using an oesophageal cell line (HET-1A)
Bioorganic &amp; Medicinal Chemistry 2010.0
Study on the structure-activity relationship of dihydroartemisinin derivatives: Discovery, synthesis, and biological evaluation of dihydroartemisinin-bile acid conjugates as potential anticancer agents
European Journal of Medicinal Chemistry 2021.0
Synthesis, in vitro and in vivo antitumor activity of pyrazole-fused 23-hydroxybetulinic acid derivatives
Bioorganic &amp; Medicinal Chemistry Letters 2015.0